Bioprocess Containers Market is Going to Hits 1,914.6 Million by 2023

Bioprocess Containers Market is expected to reach USD 1,914.6 Million by 2023 from USD 1,030.0 Million in 2018, at a CAGR of 13.2%.

(EMAILWIRE.COM, April 16, 2019 ) The major factors driving the growth of this market include the lower risk of cross-contamination, high adoption of bioprocess containers over stainless steel equipment, and increasing adoption of single-use technology in the manufacturing process of biopharmaceuticals.

Some of the major players in the bioprocess container market are Thermo Fisher Scientific (US), Sartorius (Germany), GE Healthcare (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Meissner (US), Rim Bio (US), and Fluids Control (Argentina).

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107645832

Target Audience for this Report:

-Bioprocess container manufacturers
-Life sciences R&D companies
-Distributors of bioprocesses containers
-Contract manufacturers single-use equipment and consumables
-Research institutes and clinical research organizations (CROs)
-Venture capitalists
-Bioprocess engineers
-Government associations

The bioprocess containers market is expected to reach USD 1,914.6 Million by 2023 from USD 1,030.0 Million in 2018, at a CAGR of 13.2%.

Major industry players launched innovative products and focus on expanding to maintain and improve their position in the bioprocess containers market. For instance, Merck KGaA plans to invest in the Asian region in order to build a robust manufacturing and distribution platform over a span of two years.

This investment is for establishing new biopharmaceutical manufacturing and distribution centers in South Korea and India, with the growing demand for biopharmaceutical products.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=107645832

The global bioprocess containers market is dominated by North America, followed by Europe. North America will continue to dominate the global bioprocess container market in the forecast period. The surging demand for biopharmaceuticals¡ªdue to the growing base of geriatric population¡ªis the major factor driving the market in North America. H